BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4393282)

  • 1. Effect of pronethalol on left ventricular volumes of dogs during hemorrhagic shock.
    Hackel DB; Martin AM; Capp MP; Spach MJ; Mikat E
    Am J Pathol; 1970 Jul; 60(1):93-102. PubMed ID: 4393282
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological central sympathicus block before and during experimental hemorrhagic shock].
    Allenberg JR; Becker S; Papcke U; Schmier J
    Arzneimittelforschung; 1970 Nov; 20(11):Suppl 11a:1675+. PubMed ID: 4395295
    [No Abstract]   [Full Text] [Related]  

  • 3. Phasic myocardial blood flow in hemorrhagic hypotension. Effect of beta sympathetic blockade.
    Entman ML; Martin AM; Mikat E; Chang JH; Hackel DB
    Am J Cardiol; 1968 Jun; 21(6):881-5. PubMed ID: 4385245
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of glucagon in experimental hemorrhagic shock.
    Madden JJ; Ludewig RM; Wangensteen SL
    Am J Surg; 1971 Oct; 122(4):502-4. PubMed ID: 5098655
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of phentolamine in experimental hemorrhagic shock.
    Gould L; Ettinger S; Carmichael A; Lord P; Hofstra P
    Angiology; 1970 May; 21(5):330-5. PubMed ID: 5443090
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of exogenous cyclic adenosine monophosphate in hemorrhagic shock.
    MacRae ML; Chiu CJ; Hinchey EJ
    Surgery; 1975 Aug; 78(2):254-60. PubMed ID: 168656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-receptor blockade before and during experimental hemorrhagic shock].
    Allenberg JR; Becker S; Papcke U; Schmidt HD; Schmier J
    Arztl Forsch; 1968; 22(12):412-8. PubMed ID: 5756668
    [No Abstract]   [Full Text] [Related]  

  • 8. Nylidrin HCl: a beta-sympathetic stimulant in the management of haemorrhagic shock.
    Boiteau GM; Dechêne JP
    Can Anaesth Soc J; 1966 May; 13(3):252-62. PubMed ID: 5961928
    [No Abstract]   [Full Text] [Related]  

  • 9. Balanced salt solution in the treatment of hemorrhagic shock. Studies in dogs.
    McClelland RN; Shires GT; Baxter CR; Coln CD; Carrico J
    JAMA; 1967 Mar; 199(11):830-4. PubMed ID: 6071296
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effect of prostaglandin E1 in experimental hemorrhagic shock.
    Machiedo GW; Brown CS; Lavigne JE; Rsuh BF
    Surg Gynecol Obstet; 1976 Sep; 143(3):433-6. PubMed ID: 959964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a bedside Doppler in tracking left ventricular dysfunction related to hemorrhagic shock.
    Chendrasekhar A; Prabhakar G; Pillai S; Fagerli JC; Barringer LS; Dulaney J; Timberlake GA
    Am Surg; 1997 Aug; 63(8):747-51. PubMed ID: 9247447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of 1-(4-oxyphenyl)-2n-butylamino-ethanone hydrochloride (BON) on blood circulation. I].
    Kovách AG; Böszörményi E; Bálint T; Hámori M
    Arzneimittelforschung; 1970 Nov; 20(11):Suppl 11a:1653+. PubMed ID: 4395289
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of hemorrhagic shock with WR-149,024 (1,18-diamino-6,13-diaza-9,10-dithiaoctadecane tetrahydrochloride).
    Caldwell RW; Demaree GE
    J Trauma; 1973 Nov; 13(11):1003-10. PubMed ID: 4147944
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluid resuscitation of hemorrhagic shock with hemoglobin vesicles in Beagle dogs: pilot study.
    Yamamoto M; Horinouchi H; Kobayashi K; Seishi Y; Sato N; Itoh M; Sakai H
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):179-95. PubMed ID: 22288842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin and myocardial performance in shock.
    David D; Rogel S
    Acta Anaesthesiol Belg; 1976; 27 suppl():356-62. PubMed ID: 1087824
    [No Abstract]   [Full Text] [Related]  

  • 16. [The decrease in cardiac output by the continuous administration of calcium chloride after hemorrhagic shock].
    Takekawa K; Sakanishi N; Tsunoda Y; Yokoyama K; Matsumoto I
    Masui; 1985 Jun; 34(6):785-91. PubMed ID: 4032704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemodynamic effect of the combined administration of dobutamine and ATP after hemorrhagic shock].
    Takekawa K; Sakahira K; Sakanishi N; Tsunoda Y; Yokoyama K; Ikezono E
    Masui; 1984 Feb; 33(2):131-6. PubMed ID: 6716647
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandin E1 as a therapeutic agent in hemorrhagic shock.
    Machiedo GW; Brown CS; Lavigne JE; Rush BF
    Surg Forum; 1973; 24():12-4. PubMed ID: 4805962
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is energetic-dynamic heart failure only a syndrome?].
    Hegglin R; Turina M; Krayenbühl HP
    Schweiz Med Wochenschr; 1969 May; 99(19):693-8. PubMed ID: 5785436
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms in the development of myocardial lesions in hemorrhagic shock.
    Martin AM; Hackel DB; Entman ML; Capp MP; Spach MS
    Ann N Y Acad Sci; 1969 Jan; 156(1):79-90. PubMed ID: 4400977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.